We read with interest the article recently published in HEPATOLOGY, 1 which suggested that heterozygosity for hemochromatosis C282Y mutation could be associated with more fibrosis in patients with chronic active hepatitis (CAH) owing to hepatitis C virus (HCV). Liver iron accumulation has been obser
Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C
✍ Scribed by C. Hezode; C. Cazeneuve; O. Coué; J. M. Pawlotsky; E. S. Zafrani; S. Amselem; D. Dhumeaux
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 31 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Chronic hepatitis C is often associated with liver iron overload, which may affect the long-term prognosis and the response to antiviral treatment. The occurrence of hemochromatosis (HFE) mutations were studied to determine whether may contribute to the liver iron overload of chronic hepatitis C pat
The pathogenic mechanisms of accelerated graft fibrosis in hepatitis C recurrence after liver transplantation (LT) are not well established. The aim of the study was to assess whether a greater activation of hepatic stellate cells (HSC), the major collagen-producing cells in the liver, can occur in
Mild to moderate hepatic iron overload is frequent in patients with chronic viral hepatitis (CH). We evaluated the role of hemochromatosis (HFE) gene mutations and other acquired factors in the development of iron overload in these patients. We studied 110 patients with chronic B or C viral hepatiti
The aim of this study was to investigate the relationprevalence of symptoms was retrospectively reviewed in 410 ship between iron overload, age, and clinical symptoms patients with genetic hemochromatosis. in genetic hemochromatosis. The relationship was studied between clinical symptoms and liver i
recurrence than patients with hepatitis D virus (HDV)-re-It has been suggested that Asian patients have related cirrhosis or patients with fulminant HBV infection. 3-5 duced survival after liver transplantation because of It has also been reported that the rate of HBV recurrence is greater recurrenc